Indaptus Therapeutics, Inc. (INDP) Operating cash flow 2020–2025
Indaptus Therapeutics, Inc. (INDP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$14.8MFY2025 · since FY2020: -$3.3M → -$14.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.8M | -20.3% |
| FY2024 | -$12.3M | +8.1% |
| FY2023 | -$13.4M | -2.5% |
| FY2022 | -$13.1M | -15.8% |
| FY2021 | -$11.3M | -239.6% |
| FY2020 | -$3.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INDP financial trends
INDP RevenueINDP Net incomeINDP Net marginINDP Gross profitINDP Gross marginINDP Operating incomeINDP Operating marginINDP Free cash flowINDP Capital expendituresINDP Return on equityINDP Stock buybacksINDP Dividends paidINDP Total assetsINDP Total liabilitiesINDP Shareholders’ equityINDP overview →